Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	35,312	35,889	22,555	32,012	35,749	76,786
Market Cap Growth	26.82%	59.12%	-29.54%	-10.45%	-53.44%	116.67%
Enterprise Value	30,202	30,779	22,818	31,823	33,878	71,142
Last Close Price	49.00	49.80	38.48	54.26	60.32	128.99
PE Ratio	59.04	63.44	46.13	87.34	64.61	129.11
Forward PE	42.79	29.61	29.61	46.74	89.61	89.61
PS Ratio	10.72	10.89	7.63	15.14	14.65	32.49
PB Ratio	1.66	1.69	1.49	2.17	2.38	5.23
P/TBV Ratio	2.09	2.12	2.08	3.06	3.52	7.77
P/OCF Ratio	-	-	27.48	56.22	44.48	132.69
EV/Sales Ratio	9.16	9.34	7.71	15.05	13.88	30.10
EV/EBITDA Ratio	31.76	32.36	33.56	70.52	50.43	106.53
EV/EBIT Ratio	47.56	48.46	62.70	192.23	83.32	142.50
Debt / Equity Ratio	0.01	0.01	0.13	0.12	0.08	0.05
Debt / EBITDA Ratio	0.29	0.29	2.79	3.94	1.68	1.11
Net Debt / Equity Ratio	-0.41	-0.41	-0.23	-0.24	-0.34	-0.61
Net Debt / EBITDA Ratio	-9.18	-9.18	-5.07	-8.01	-7.69	-13.31
Net Debt / FCF Ratio	-	-	154.13	3.61	1.52	10.09
Asset Turnover	-	-	0.16	0.12	0.14	0.17
Inventory Turnover	-	-	1.60	1.01	1.17	1.56
Quick Ratio	-	-	1.99	1.70	4.75	8.14
Current Ratio	-	-	2.53	2.22	5.95	9.36
Return on Equity (ROE)	3.12%	3.12%	3.18%	2.74%	4.12%	4.84%
Return on Assets (ROA)	-	-	1.20%	0.56%	1.49%	2.20%
Return on Invested Capital (ROIC)	4.56%	4.71%	2.76%	1.43%	4.57%	7.95%
Return on Capital Employed (ROCE)	-	-	2.30%	1.10%	2.50%	3.30%
Earnings Yield	1.60%	1.58%	2.17%	1.15%	1.55%	0.78%
FCF Yield	-	-	-0.10%	-3.13%	-9.50%	-1.15%
Dividend Yield	0.82%	-	1.04%	0.35%	0.30%	0.25%
Payout Ratio	-	-	28.80%	37.58%	37.39%	57.11%
Buyback Yield / Dilution	-17.09%	-17.09%	-0.05%	0.10%	0.11%	-7.38%
Total Shareholder Return	-16.28%	-17.09%	0.99%	0.45%	0.41%	-7.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.